Literature DB >> 12900765

Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.

C-T Yang1, J Song, X Bu, Y-S Cong, S Bacchetti, P Rennie, W W-G Jia.   

Abstract

Targeted gene expression through viral vectors has been a promising approach for gene therapy. However, the effects of viral gene products expressed from virus vectors on the expression of the host gene are not well known. In the present study, we examined the activities of cellular promoters, including the promoter for genes of human telomerase reverse transcriptase (hTERT), tyrosinase and probasin, in both tumor and normal cells after infection with herpes simplex virus type 1 (HSV-1) vectors. Our results showed that infection with replication-defective HSV-1 vectors significantly upregulated the activity of all three cellular promoters in a nonsequence specific fashion in all cell types tested. Furthermore, viral infection upregulated activities of the hTERT promoter and endogenous telomerase in nontumoral cells. Additional experiments suggested that the viral immediate-early gene product, infected cell protein 0, might be responsible for the deregulation of cellular promoter activity and activation of telomerase. Our study alerts to the potential risk of oncogenesis through deregulation of host gene expression, such as the telomerase by viral vectors in normal cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900765     DOI: 10.1038/sj.gt.3302005

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  16 in total

1.  Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.

Authors:  Taeyoung Koo; Il-Kyu Choi; Minjung Kim; Jung-Sun Lee; Eonju Oh; Jungho Kim; Chae-Ok Yun
Journal:  Hum Gene Ther       Date:  2012-02-21       Impact factor: 5.695

2.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

3.  ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN.

Authors:  J Carson; D Haddad; M Bressman; Y Fong
Journal:  Drugs Future       Date:  2010       Impact factor: 0.148

4.  Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors.

Authors:  Cleo Y F Lee; Luke X X Bu; Arrigo DeBenedetti; B Jill Williams; Paul S Rennie; William W G Jia
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

5.  The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.

Authors:  Jarod Haberichter; Scott Roberts; Imran Abbasi; Phonphanh Dedthanou; Prajakta Pradhan; Marie L Nguyen
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 6.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

7.  The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses.

Authors:  Alexander V Kofman; Christopher Letson; Evan Dupart; Yongde Bao; William W Newcomb; David Schiff; Jay Brown; Roger Abounader
Journal:  Med Hypotheses       Date:  2013-05-02       Impact factor: 1.538

Review 8.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

9.  Conditionally replicating adenovirus prevents pluripotent stem cell-derived teratoma by specifically eliminating undifferentiated cells.

Authors:  Kaoru Mitsui; Kanako Ide; Akiko Takayama; Tadahisa Wada; Rie Irie; Ken-Ichiro Kosai
Journal:  Mol Ther Methods Clin Dev       Date:  2015-08-12       Impact factor: 6.698

10.  Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation.

Authors:  Jimi L Rosenkrantz; Jessica E Gaffney; Victoria H J Roberts; Lucia Carbone; Shawn L Chavez
Journal:  BMC Biol       Date:  2021-06-21       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.